Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for quantifying the human proteome, today announced the appointment of Nick Nelson as Chief Business Officer.
Joerg Ahlgrimm Appointed as President and COO of The Discovery Labs.
Emmes President and CEO, Dr. Christine Dingivan
Gary Nabors, Ph.D. Joins Integrated BioTherapeutics Inc. as Executive Vice President and Chief Development Officer
Gary Nabors, Ph.D. Joins Integrated BioTherapeutics Inc. as Executive Vice President and Chief Development Officer Integrated BioTherapeutics Inc. (IBT), a Maryland company specializing in emerging infectious diseases, announced today Dr. [….]
ABL, Inc. (ABL), a leading global viral vector contract manufacturing and research testing service provider to the biopharmaceutical industry, announces the hire of Diana Elias as HR Director.
Reinhard is the Chairman of Scientific Bioprocessing Inc. and serves on the Board of our parent company, Scientific Industries.
Veralox Therapeutics Appoints Life Sciences Industry Veteran Alex Martin as Chairman of the Board of Directors
Mr. Martin brings to the Chairman’s role over 25 years of experience in senior executive roles in the life sciences industry, with a focus on business development, operations, and financing.
Amanda L. Murphy Appointed as Chief Financial Officer to MaxCyte
MaxCyte Appoints Amanda L. Murphy as Chief Financial Officer and Names Ron Holtz as Senior Vice President & Chief Accounting Officer
MaxCyte, Inc., a global cell-based therapies and life sciences company, announced today that Amanda L. Murphy, CFA, has joined the Company as Chief Financial Officer (CFO). Ron Holtz, who has served as MaxCyte’s CFO since 2005, will become Senior Vice President and Chief Accounting Officer (SVP & CAO).
Griffin St Louis Joins TEDCO as Program Manager, Maryland Innovation Initiative (MII)